Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 232 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2019-11-20 | 2021-09-01 | 99317 |
APO-AMLODIPINE | 5MG | TABLET | Resolved | 2021-08-16 | 2021-09-07 | 144198 |
APO-LORAZEPAM | 2MG | TABLET | Resolved | 2021-08-03 | 2021-09-07 | 143401 |
APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2021-08-16 | 2021-09-07 | 144209 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Resolved | 2021-07-23 | 2021-09-14 | 142967 |
APO-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-06-25 | 2021-09-14 | 141540 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2021-08-27 | 2021-09-14 | 144669 |
APO-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-06-04 | 2021-09-20 | 116536 |
APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-10-23 | 2021-09-20 | 97040 |
APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-10-23 | 2021-09-20 | 97043 |
APO-DOXY CAP 100MG | 100MG | CAPSULE | Resolved | 2021-09-03 | 2021-09-20 | 145147 |
APO-FLUCONAZOLE-150 | 150MG | CAPSULE CAPSULE | Resolved | 2021-05-25 | 2021-09-20 | 139837 |
APO-LORAZEPAM | 0.5MG | TABLET | Resolved | 2021-06-18 | 2021-09-20 | 141244 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-05-07 | 2021-09-20 | 138960 |
APO-PIOGLITAZONE | 30MG | TABLET | Resolved | 2021-09-03 | 2021-09-20 | 145178 |
APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2021-09-17 | 2021-09-27 | 145818 |
APO-ALENDRONATE | 70MG | TABLET | Resolved | 2021-07-09 | 2021-09-27 | 142269 |
APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2021-08-03 | 2021-09-27 | 143397 |
APO-DONEPEZIL | 10MG | TABLET | Resolved | 2021-09-17 | 2021-09-27 | 145834 |
APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-10-23 | 2021-09-27 | 97037 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |
IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-07-12 | 2019-07-13 | 89135 |
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-08-07 | 2019-08-07 | 91117 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2019-08-08 | 60420 |
APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-08-08 | 70807 |
APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60772 |
APO-OXAZEPAM | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-08-30 | 60675 |
APO-TAMOX TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-09-12 | 61050 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |
APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2018-09-07 | 2019-12-20 | 60163 |